ArticleFrontiers in immunology2025

Targeting IL-6 receptor mediated metabolic pathways to control Th17 cell differentiation and inflammatory responses.

Yazan Alwarawrah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.